 | • レポートコード：MRC2-11QY04905 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は腫瘍バイオマーカー検査のグローバル市場について調査・分析したレポートです。種類別（前立腺特異抗原検査、CTC検査、α-フェトプロテイン（AFP）検査、CA検査、HER2検査、BRCA検査、未分化リンパ腫キナーゼ（ALK）検査、EGFR変異検査、KRAS検査、その他）市場規模、用途別（肺がん、乳がん、結腸直腸がん、前立腺がん、血液がん）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別腫瘍バイオマーカー検査の競争状況、市場シェア ・世界の腫瘍バイオマーカー検査市場：種類別市場規模 2015年-2020年（前立腺特異抗原検査、CTC検査、α-フェトプロテイン（AFP）検査、CA検査、HER2検査、BRCA検査、未分化リンパ腫キナーゼ（ALK）検査、EGFR変異検査、KRAS検査、その他） ・世界の腫瘍バイオマーカー検査市場：種類別市場規模予測 2021年-2026年（前立腺特異抗原検査、CTC検査、α-フェトプロテイン（AFP）検査、CA検査、HER2検査、BRCA検査、未分化リンパ腫キナーゼ（ALK）検査、EGFR変異検査、KRAS検査、その他） ・世界の腫瘍バイオマーカー検査市場：用途別市場規模 2015年-2020年（肺がん、乳がん、結腸直腸がん、前立腺がん、血液がん） ・世界の腫瘍バイオマーカー検査市場：用途別市場規模予測 2021年-2026年（肺がん、乳がん、結腸直腸がん、前立腺がん、血液がん） ・北米の腫瘍バイオマーカー検査市場分析：米国、カナダ ・ヨーロッパの腫瘍バイオマーカー検査市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの腫瘍バイオマーカー検査市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の腫瘍バイオマーカー検査市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの腫瘍バイオマーカー検査市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories, Inc.、Agilent Technologies、AstraZeneca、Becton Dickinson & Co.、Biocept Inc.、Cancer Genetics Inc.、Danaher Corporation、Foundation Medicine Inc.、Illumina Inc.、LabCorp Of America Holdings、Luminex Corporation、Myriad Genetics Inc.、NanoString Technologies Inc. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Tumor Biomarker Test Market
The global Tumor Biomarker Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Tumor Biomarker Test Scope and Market Size
Tumor Biomarker Test market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tumor Biomarker Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories, Inc.
Agilent Technologies
AstraZeneca
Becton Dickinson & Co.
Biocept Inc.
Cancer Genetics Inc.
Danaher Corporation
Foundation Medicine Inc.
Illumina Inc.
LabCorp Of America Holdings
Luminex Corporation
Myriad Genetics Inc.
NanoString Technologies Inc.
Market segment by Type, the product can be split into
Prostate Specific Antigen Tests
CTC Tests
Alpha-Fetoprotein (AFP) Tests
CA Test
HER2 Tests
BRCA Test
Anaplastic Lymphoma Kinase (ALK) Tests
EGFR Mutation Tests
KRAS Test
Others
Market segment by Application, split into
Lung cancer
Breast cancer
Colorectal
Prostate Cancer
Blood Cancer
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Tumor Biomarker Test Revenue
1.4 Market by Type
1.4.1 Global Tumor Biomarker Test Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Prostate Specific Antigen Tests
1.4.3 CTC Tests
1.4.4 Alpha-Fetoprotein (AFP) Tests
1.4.5 CA Test
1.4.6 HER2 Tests
1.4.7 BRCA Test
1.4.8 Anaplastic Lymphoma Kinase (ALK) Tests
1.4.9 EGFR Mutation Tests
1.4.10 KRAS Test
1.4.11 Others
1.5 Market by Application
1.5.1 Global Tumor Biomarker Test Market Share by Application: 2020 VS 2026
1.5.2 Lung cancer
1.5.3 Breast cancer
1.5.4 Colorectal
1.5.5 Prostate Cancer
1.5.6 Blood Cancer
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Tumor Biomarker Test Market Perspective (2015-2026)
2.2 Global Tumor Biomarker Test Growth Trends by Regions
2.2.1 Tumor Biomarker Test Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Tumor Biomarker Test Historic Market Share by Regions (2015-2020)
2.2.3 Tumor Biomarker Test Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Tumor Biomarker Test Market Growth Strategy
2.3.6 Primary Interviews with Key Tumor Biomarker Test Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Tumor Biomarker Test Players by Market Size
3.1.1 Global Top Tumor Biomarker Test Players by Revenue (2015-2020)
3.1.2 Global Tumor Biomarker Test Revenue Market Share by Players (2015-2020)
3.1.3 Global Tumor Biomarker Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Tumor Biomarker Test Market Concentration Ratio
3.2.1 Global Tumor Biomarker Test Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Tumor Biomarker Test Revenue in 2019
3.3 Tumor Biomarker Test Key Players Head office and Area Served
3.4 Key Players Tumor Biomarker Test Product Solution and Service
3.5 Date of Enter into Tumor Biomarker Test Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Tumor Biomarker Test Historic Market Size by Type (2015-2020)
4.2 Global Tumor Biomarker Test Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Tumor Biomarker Test Market Size by Application (2015-2020)
5.2 Global Tumor Biomarker Test Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Tumor Biomarker Test Market Size (2015-2020)
6.2 Tumor Biomarker Test Key Players in North America (2019-2020)
6.3 North America Tumor Biomarker Test Market Size by Type (2015-2020)
6.4 North America Tumor Biomarker Test Market Size by Application (2015-2020)
7 Europe
7.1 Europe Tumor Biomarker Test Market Size (2015-2020)
7.2 Tumor Biomarker Test Key Players in Europe (2019-2020)
7.3 Europe Tumor Biomarker Test Market Size by Type (2015-2020)
7.4 Europe Tumor Biomarker Test Market Size by Application (2015-2020)
8 China
8.1 China Tumor Biomarker Test Market Size (2015-2020)
8.2 Tumor Biomarker Test Key Players in China (2019-2020)
8.3 China Tumor Biomarker Test Market Size by Type (2015-2020)
8.4 China Tumor Biomarker Test Market Size by Application (2015-2020)
9 Japan
9.1 Japan Tumor Biomarker Test Market Size (2015-2020)
9.2 Tumor Biomarker Test Key Players in Japan (2019-2020)
9.3 Japan Tumor Biomarker Test Market Size by Type (2015-2020)
9.4 Japan Tumor Biomarker Test Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Tumor Biomarker Test Market Size (2015-2020)
10.2 Tumor Biomarker Test Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Tumor Biomarker Test Market Size by Type (2015-2020)
10.4 Southeast Asia Tumor Biomarker Test Market Size by Application (2015-2020)
11 India
11.1 India Tumor Biomarker Test Market Size (2015-2020)
11.2 Tumor Biomarker Test Key Players in India (2019-2020)
11.3 India Tumor Biomarker Test Market Size by Type (2015-2020)
11.4 India Tumor Biomarker Test Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Tumor Biomarker Test Market Size (2015-2020)
12.2 Tumor Biomarker Test Key Players in Central & South America (2019-2020)
12.3 Central & South America Tumor Biomarker Test Market Size by Type (2015-2020)
12.4 Central & South America Tumor Biomarker Test Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories, Inc.
13.1.1 Abbott Laboratories, Inc. Company Details
13.1.2 Abbott Laboratories, Inc. Business Overview
13.1.3 Abbott Laboratories, Inc. Tumor Biomarker Test Introduction
13.1.4 Abbott Laboratories, Inc. Revenue in Tumor Biomarker Test Business (2015-2020))
13.1.5 Abbott Laboratories, Inc. Recent Development
13.2 Agilent Technologies
13.2.1 Agilent Technologies Company Details
13.2.2 Agilent Technologies Business Overview
13.2.3 Agilent Technologies Tumor Biomarker Test Introduction
13.2.4 Agilent Technologies Revenue in Tumor Biomarker Test Business (2015-2020)
13.2.5 Agilent Technologies Recent Development
13.3 AstraZeneca
13.3.1 AstraZeneca Company Details
13.3.2 AstraZeneca Business Overview
13.3.3 AstraZeneca Tumor Biomarker Test Introduction
13.3.4 AstraZeneca Revenue in Tumor Biomarker Test Business (2015-2020)
13.3.5 AstraZeneca Recent Development
13.4 Becton Dickinson & Co.
13.4.1 Becton Dickinson & Co. Company Details
13.4.2 Becton Dickinson & Co. Business Overview
13.4.3 Becton Dickinson & Co. Tumor Biomarker Test Introduction
13.4.4 Becton Dickinson & Co. Revenue in Tumor Biomarker Test Business (2015-2020)
13.4.5 Becton Dickinson & Co. Recent Development
13.5 Biocept Inc.
13.5.1 Biocept Inc. Company Details
13.5.2 Biocept Inc. Business Overview
13.5.3 Biocept Inc. Tumor Biomarker Test Introduction
13.5.4 Biocept Inc. Revenue in Tumor Biomarker Test Business (2015-2020)
13.5.5 Biocept Inc. Recent Development
13.6 Cancer Genetics Inc.
13.6.1 Cancer Genetics Inc. Company Details
13.6.2 Cancer Genetics Inc. Business Overview
13.6.3 Cancer Genetics Inc. Tumor Biomarker Test Introduction
13.6.4 Cancer Genetics Inc. Revenue in Tumor Biomarker Test Business (2015-2020)
13.6.5 Cancer Genetics Inc. Recent Development
13.7 Danaher Corporation
13.7.1 Danaher Corporation Company Details
13.7.2 Danaher Corporation Business Overview
13.7.3 Danaher Corporation Tumor Biomarker Test Introduction
13.7.4 Danaher Corporation Revenue in Tumor Biomarker Test Business (2015-2020)
13.7.5 Danaher Corporation Recent Development
13.8 Foundation Medicine Inc.
13.8.1 Foundation Medicine Inc. Company Details
13.8.2 Foundation Medicine Inc. Business Overview
13.8.3 Foundation Medicine Inc. Tumor Biomarker Test Introduction
13.8.4 Foundation Medicine Inc. Revenue in Tumor Biomarker Test Business (2015-2020)
13.8.5 Foundation Medicine Inc. Recent Development
13.9 Illumina Inc.
13.9.1 Illumina Inc. Company Details
13.9.2 Illumina Inc. Business Overview
13.9.3 Illumina Inc. Tumor Biomarker Test Introduction
13.9.4 Illumina Inc. Revenue in Tumor Biomarker Test Business (2015-2020)
13.9.5 Illumina Inc. Recent Development
13.10 LabCorp Of America Holdings
13.10.1 LabCorp Of America Holdings Company Details
13.10.2 LabCorp Of America Holdings Business Overview
13.10.3 LabCorp Of America Holdings Tumor Biomarker Test Introduction
13.10.4 LabCorp Of America Holdings Revenue in Tumor Biomarker Test Business (2015-2020)
13.10.5 LabCorp Of America Holdings Recent Development
13.11 Luminex Corporation
10.11.1 Luminex Corporation Company Details
10.11.2 Luminex Corporation Business Overview
10.11.3 Luminex Corporation Tumor Biomarker Test Introduction
10.11.4 Luminex Corporation Revenue in Tumor Biomarker Test Business (2015-2020)
10.11.5 Luminex Corporation Recent Development
13.12 Myriad Genetics Inc.
10.12.1 Myriad Genetics Inc. Company Details
10.12.2 Myriad Genetics Inc. Business Overview
10.12.3 Myriad Genetics Inc. Tumor Biomarker Test Introduction
10.12.4 Myriad Genetics Inc. Revenue in Tumor Biomarker Test Business (2015-2020)
10.12.5 Myriad Genetics Inc. Recent Development
13.13 NanoString Technologies Inc.
10.13.1 NanoString Technologies Inc. Company Details
10.13.2 NanoString Technologies Inc. Business Overview
10.13.3 NanoString Technologies Inc. Tumor Biomarker Test Introduction
10.13.4 NanoString Technologies Inc. Revenue in Tumor Biomarker Test Business (2015-2020)
10.13.5 NanoString Technologies Inc. Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Tumor Biomarker Test Key Market Segments
Table 2. Key Players Covered: Ranking by Tumor Biomarker Test Revenue
Table 3. Ranking of Global Top Tumor Biomarker Test Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Tumor Biomarker Test Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Prostate Specific Antigen Tests
Table 6. Key Players of CTC Tests
Table 7. Key Players of Alpha-Fetoprotein (AFP) Tests
Table 8. Key Players of CA Test
Table 9. Key Players of HER2 Tests
Table 10. Key Players of BRCA Test
Table 11. Key Players of Anaplastic Lymphoma Kinase (ALK) Tests
Table 12. Key Players of EGFR Mutation Tests
Table 13. Key Players of KRAS Test
Table 14. Key Players of Others
Table 15. Global Tumor Biomarker Test Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Tumor Biomarker Test Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Tumor Biomarker Test Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Tumor Biomarker Test Market Share by Regions (2015-2020)
Table 19. Global Tumor Biomarker Test Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Tumor Biomarker Test Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Tumor Biomarker Test Market Growth Strategy
Table 25. Main Points Interviewed from Key Tumor Biomarker Test Players
Table 26. Global Tumor Biomarker Test Revenue by Players (2015-2020) (Million US$)
Table 27. Global Tumor Biomarker Test Market Share by Players (2015-2020)
Table 28. Global Top Tumor Biomarker Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Biomarker Test as of 2019)
Table 29. Global Tumor Biomarker Test by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Tumor Biomarker Test Product Solution and Service
Table 32. Date of Enter into Tumor Biomarker Test Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Tumor Biomarker Test Market Size by Type (2015-2020) (Million US$)
Table 35. Global Tumor Biomarker Test Market Size Share by Type (2015-2020)
Table 36. Global Tumor Biomarker Test Revenue Market Share by Type (2021-2026)
Table 37. Global Tumor Biomarker Test Market Size Share by Application (2015-2020)
Table 38. Global Tumor Biomarker Test Market Size by Application (2015-2020) (Million US$)
Table 39. Global Tumor Biomarker Test Market Size Share by Application (2021-2026)
Table 40. North America Key Players Tumor Biomarker Test Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Tumor Biomarker Test Market Share (2019-2020)
Table 42. North America Tumor Biomarker Test Market Size by Type (2015-2020) (Million US$)
Table 43. North America Tumor Biomarker Test Market Share by Type (2015-2020)
Table 44. North America Tumor Biomarker Test Market Size by Application (2015-2020) (Million US$)
Table 45. North America Tumor Biomarker Test Market Share by Application (2015-2020)
Table 46. Europe Key Players Tumor Biomarker Test Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Tumor Biomarker Test Market Share (2019-2020)
Table 48. Europe Tumor Biomarker Test Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Tumor Biomarker Test Market Share by Type (2015-2020)
Table 50. Europe Tumor Biomarker Test Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Tumor Biomarker Test Market Share by Application (2015-2020)
Table 52. China Key Players Tumor Biomarker Test Revenue (2019-2020) (Million US$)
Table 53. China Key Players Tumor Biomarker Test Market Share (2019-2020)
Table 54. China Tumor Biomarker Test Market Size by Type (2015-2020) (Million US$)
Table 55. China Tumor Biomarker Test Market Share by Type (2015-2020)
Table 56. China Tumor Biomarker Test Market Size by Application (2015-2020) (Million US$)
Table 57. China Tumor Biomarker Test Market Share by Application (2015-2020)
Table 58. Japan Key Players Tumor Biomarker Test Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Tumor Biomarker Test Market Share (2019-2020)
Table 60. Japan Tumor Biomarker Test Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Tumor Biomarker Test Market Share by Type (2015-2020)
Table 62. Japan Tumor Biomarker Test Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Tumor Biomarker Test Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Tumor Biomarker Test Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Tumor Biomarker Test Market Share (2019-2020)
Table 66. Southeast Asia Tumor Biomarker Test Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Tumor Biomarker Test Market Share by Type (2015-2020)
Table 68. Southeast Asia Tumor Biomarker Test Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Tumor Biomarker Test Market Share by Application (2015-2020)
Table 70. India Key Players Tumor Biomarker Test Revenue (2019-2020) (Million US$)
Table 71. India Key Players Tumor Biomarker Test Market Share (2019-2020)
Table 72. India Tumor Biomarker Test Market Size by Type (2015-2020) (Million US$)
Table 73. India Tumor Biomarker Test Market Share by Type (2015-2020)
Table 74. India Tumor Biomarker Test Market Size by Application (2015-2020) (Million US$)
Table 75. India Tumor Biomarker Test Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Tumor Biomarker Test Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Tumor Biomarker Test Market Share (2019-2020)
Table 78. Central & South America Tumor Biomarker Test Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Tumor Biomarker Test Market Share by Type (2015-2020)
Table 80. Central & South America Tumor Biomarker Test Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Tumor Biomarker Test Market Share by Application (2015-2020)
Table 82. Abbott Laboratories, Inc. Company Details
Table 83. Abbott Laboratories, Inc. Business Overview
Table 84. Abbott Laboratories, Inc. Product
Table 85. Abbott Laboratories, Inc. Revenue in Tumor Biomarker Test Business (2015-2020) (Million US$)
Table 86. Abbott Laboratories, Inc. Recent Development
Table 87. Agilent Technologies Company Details
Table 88. Agilent Technologies Business Overview
Table 89. Agilent Technologies Product
Table 90. Agilent Technologies Revenue in Tumor Biomarker Test Business (2015-2020) (Million US$)
Table 91. Agilent Technologies Recent Development
Table 92. AstraZeneca Company Details
Table 93. AstraZeneca Business Overview
Table 94. AstraZeneca Product
Table 95. AstraZeneca Revenue in Tumor Biomarker Test Business (2015-2020) (Million US$)
Table 96. AstraZeneca Recent Development
Table 97. Becton Dickinson & Co. Company Details
Table 98. Becton Dickinson & Co. Business Overview
Table 99. Becton Dickinson & Co. Product
Table 100. Becton Dickinson & Co. Revenue in Tumor Biomarker Test Business (2015-2020) (Million US$)
Table 101. Becton Dickinson & Co. Recent Development
Table 102. Biocept Inc. Company Details
Table 103. Biocept Inc. Business Overview
Table 104. Biocept Inc. Product
Table 105. Biocept Inc. Revenue in Tumor Biomarker Test Business (2015-2020) (Million US$)
Table 106. Biocept Inc. Recent Development
Table 107. Cancer Genetics Inc. Company Details
Table 108. Cancer Genetics Inc. Business Overview
Table 109. Cancer Genetics Inc. Product
Table 110. Cancer Genetics Inc. Revenue in Tumor Biomarker Test Business (2015-2020) (Million US$)
Table 111. Cancer Genetics Inc. Recent Development
Table 112. Danaher Corporation Company Details
Table 113. Danaher Corporation Business Overview
Table 114. Danaher Corporation Product
Table 115. Danaher Corporation Revenue in Tumor Biomarker Test Business (2015-2020) (Million US$)
Table 116. Danaher Corporation Recent Development
Table 117. Foundation Medicine Inc. Business Overview
Table 118. Foundation Medicine Inc. Product
Table 119. Foundation Medicine Inc. Company Details
Table 120. Foundation Medicine Inc. Revenue in Tumor Biomarker Test Business (2015-2020) (Million US$)
Table 121. Foundation Medicine Inc. Recent Development
Table 122. Illumina Inc. Company Details
Table 123. Illumina Inc. Business Overview
Table 124. Illumina Inc. Product
Table 125. Illumina Inc. Revenue in Tumor Biomarker Test Business (2015-2020) (Million US$)
Table 126. Illumina Inc. Recent Development
Table 127. LabCorp Of America Holdings Company Details
Table 128. LabCorp Of America Holdings Business Overview
Table 129. LabCorp Of America Holdings Product
Table 130. LabCorp Of America Holdings Revenue in Tumor Biomarker Test Business (2015-2020) (Million US$)
Table 131. LabCorp Of America Holdings Recent Development
Table 132. Luminex Corporation Company Details
Table 133. Luminex Corporation Business Overview
Table 134. Luminex Corporation Product
Table 135. Luminex Corporation Revenue in Tumor Biomarker Test Business (2015-2020) (Million US$)
Table 136. Luminex Corporation Recent Development
Table 137. Myriad Genetics Inc. Company Details
Table 138. Myriad Genetics Inc. Business Overview
Table 139. Myriad Genetics Inc. Product
Table 140. Myriad Genetics Inc. Revenue in Tumor Biomarker Test Business (2015-2020) (Million US$)
Table 141. Myriad Genetics Inc. Recent Development
Table 142. NanoString Technologies Inc. Company Details
Table 143. NanoString Technologies Inc. Business Overview
Table 144. NanoString Technologies Inc. Product
Table 145. NanoString Technologies Inc. Revenue in Tumor Biomarker Test Business (2015-2020) (Million US$)
Table 146. NanoString Technologies Inc. Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tumor Biomarker Test Market Share by Type: 2020 VS 2026
Figure 2. Prostate Specific Antigen Tests Features
Figure 3. CTC Tests Features
Figure 4. Alpha-Fetoprotein (AFP) Tests Features
Figure 5. CA Test Features
Figure 6. HER2 Tests Features
Figure 7. BRCA Test Features
Figure 8. Anaplastic Lymphoma Kinase (ALK) Tests Features
Figure 9. EGFR Mutation Tests Features
Figure 10. KRAS Test Features
Figure 11. Others Features
Figure 12. Global Tumor Biomarker Test Market Share by Application: 2020 VS 2026
Figure 13. Lung cancer Case Studies
Figure 14. Breast cancer Case Studies
Figure 15. Colorectal Case Studies
Figure 16. Prostate Cancer Case Studies
Figure 17. Blood Cancer Case Studies
Figure 18. Tumor Biomarker Test Report Years Considered
Figure 19. Global Tumor Biomarker Test Market Size YoY Growth 2015-2026 (US$ Million)
Figure 20. Global Tumor Biomarker Test Market Share by Regions: 2020 VS 2026
Figure 21. Global Tumor Biomarker Test Market Share by Regions (2021-2026)
Figure 22. Porter's Five Forces Analysis
Figure 23. Global Tumor Biomarker Test Market Share by Players in 2019
Figure 24. Global Top Tumor Biomarker Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Biomarker Test as of 2019
Figure 25. The Top 10 and 5 Players Market Share by Tumor Biomarker Test Revenue in 2019
Figure 26. North America Tumor Biomarker Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Europe Tumor Biomarker Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. China Tumor Biomarker Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Japan Tumor Biomarker Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Southeast Asia Tumor Biomarker Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. India Tumor Biomarker Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 32. Central & South America Tumor Biomarker Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 33. Bottom-up and Top-down Approaches for This Report
Figure 34. Data Triangulation
Figure 35. Key Executives Interviewed
E型肝炎診断検査の世界市場（～2026年） Hepatitis E is a virus that affects your liver. Market Analysis and Insights: Global Hepatitis E Diagnostic Tests Market The global Hepatitis E Diagnostic Tests market size is projected to reach US$ 43 million by 2026, from US$ 42 million in 2020, at a CAGR of 2.2%% during 2021-2026. Global Hepatiti…- EGFR変異検査の世界市場（～2026年） Epidermal growth factor receptor (EGFR) is a type of protein, which is located on the surface of human body cells. Any mutation in EGFR gene can lead to various types of cancer. EGFR functions as a biomarker for non-small cell lung cancer (NSCLC) and due to the mutation of EGFR gene a person may suf…
- 甲状腺機能検査の世界市場（～2026年） Thyroid Function Tests (TFT) include various blood tests which are conducted to identify the functions of thyroid gland. The rise in prevalence of thyroid diseases is estimated to be one of the primary growth factors for the thyroid functioning tests market. The excess or deficiency of thyroid hormo…
- 肺がん診断検査の世界市場（～2026年） Market Analysis and Insights: Global Lung Cancer Diagnostic Tests Market The global Lung Cancer Diagnostic Tests market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Lung Cancer Diagnostic Tests Scope and Market Size Lung C…
- 尿検査の世界市場（～2026年） Urinalysis is a urine test to detect and manage disorders such as urinary tract infections (UTIs), liver disease, kidney disease, and diabetes. The Americas is the largest market for urinalysis test owing to the rising demand for automated urine analyzers, technological advancement, and rising preva…